AI assistant
Anterix Inc. — Director's Dealing 2020
Sep 4, 2020
33018_dirs_2020-09-03_018df4ad-cde4-4c03-8d97-6a6ff4138b5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2020-09-02
Reporting Person: Schwartz Robert Harris (President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-02 | Common Stock | A | 10128 | $0.00 | Acquired | 47343 | Direct |
| 2020-09-03 | Common Stock | S | 6493 | $42.7012 | Disposed | 40850 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-02 | Stock Option (Right to Buy) | $46.85 | A | 7318 | Acquired | 2025-08-29 | Common Stock (7318) | Direct |
Footnotes
F1: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
F2: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016 and February 2020.
F3: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.22 to $42.7034. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported stock option.